Toll Free: 1-888-928-9744
Toll Free: 1-888-928-9744
Published: Feb, 2018 | Pages:
110 | Publisher: QYResearch
Industry: Pharmaceuticals & Healthcare | Report Format: Electronic (PDF)
In this report, the United States Engineered T Cells market is valued at USD XX million in 2017 and is expected to reach USD XX million by the end of 2025, growing at a CAGR of XX% between 2017 and 2025.
Geographically, this report splits the United States market into seven regions:
The West
Southwest
The Middle Atlantic
New England
The South
The Midwest
with sales (volume), revenue (value), market share and growth rate of Engineered T Cells in these regions, from 2013 to 2025 (forecast).
United States Engineered T Cells market competition by top manufacturers/players, with Engineered T Cells sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including
Autolus Limited
Bellicum Pharmaceuticals
Cells Medica
Elli Lilly and Company
Gilead Sciences
Juno Therapeutics
Novartis
Oxford Biomedica
Pfizer
Precision Bioscience
Redmile Group
Seeking Alpha
Unum Therapeutics
On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
Tumor Infiltrating Lymphocytes
T Cell Receptor {TCR}
Chimeric Antigen Receptor (CAR)
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including
Hospitals
Cancer Research Centers
Clinics
If you have any special requirements, please let us know and we will offer you the report as you want.
Table of Contents
United States Engineered T Cells Market Report 2018
1 Engineered T Cells Overview
1.1 Product Overview and Scope of Engineered T Cells
1.2 Classification of Engineered T Cells by Product Category
1.2.1 United States Engineered T Cells Market Size (Sales Volume) Comparison by Type (2013-2025)
1.2.2 United States Engineered T Cells Market Size (Sales Volume) Market Share by Type (Product Category) in 2017
1.2.3 Tumor Infiltrating Lymphocytes
1.2.4 T Cell Receptor {TCR}
1.2.5 Chimeric Antigen Receptor (CAR)
1.3 United States Engineered T Cells Market by Application/End Users
1.3.1 United States Engineered T Cells Market Size (Consumption) and Market Share Comparison by Application (2013-2025)
1.3.2 Hospitals
1.3.3 Cancer Research Centers
1.3.4 Clinics
1.4 United States Engineered T Cells Market by Region
1.4.1 United States Engineered T Cells Market Size (Value) Comparison by Region (2013-2025)
1.4.2 The West Engineered T Cells Status and Prospect (2013-2025)
1.4.3 Southwest Engineered T Cells Status and Prospect (2013-2025)
1.4.4 The Middle Atlantic Engineered T Cells Status and Prospect (2013-2025)
1.4.5 New England Engineered T Cells Status and Prospect (2013-2025)
1.4.6 The South Engineered T Cells Status and Prospect (2013-2025)
1.4.7 The Midwest Engineered T Cells Status and Prospect (2013-2025)
1.5 United States Market Size (Value and Volume) of Engineered T Cells (2013-2025)
1.5.1 United States Engineered T Cells Sales and Growth Rate (2013-2025)
1.5.2 United States Engineered T Cells Revenue and Growth Rate (2013-2025)
2 United States Engineered T Cells Market Competition by Players/Suppliers
2.1 United States Engineered T Cells Sales and Market Share of Key Players/Suppliers (2013-2018)
2.2 United States Engineered T Cells Revenue and Share by Players/Suppliers (2013-2018)
2.3 United States Engineered T Cells Average Price by Players/Suppliers (2013-2018)
2.4 United States Engineered T Cells Market Competitive Situation and Trends
2.4.1 United States Engineered T Cells Market Concentration Rate
2.4.2 United States Engineered T Cells Market Share of Top 3 and Top 5 Players/Suppliers
2.4.3 Mergers & Acquisitions, Expansion in United States Market
2.5 United States Players/Suppliers Engineered T Cells Manufacturing Base Distribution, Sales Area, Product Type
3 United States Engineered T Cells Sales (Volume) and Revenue (Value) by Region (2013-2018)
3.1 United States Engineered T Cells Sales and Market Share by Region (2013-2018)
3.2 United States Engineered T Cells Revenue and Market Share by Region (2013-2018)
3.3 United States Engineered T Cells Price by Region (2013-2018)
4 United States Engineered T Cells Sales (Volume) and Revenue (Value) by Type (Product Category) (2013-2018)
4.1 United States Engineered T Cells Sales and Market Share by Type (Product Category) (2013-2018)
4.2 United States Engineered T Cells Revenue and Market Share by Type (2013-2018)
4.3 United States Engineered T Cells Price by Type (2013-2018)
4.4 United States Engineered T Cells Sales Growth Rate by Type (2013-2018)
5 United States Engineered T Cells Sales (Volume) by Application (2013-2018)
5.1 United States Engineered T Cells Sales and Market Share by Application (2013-2018)
5.2 United States Engineered T Cells Sales Growth Rate by Application (2013-2018)
5.3 Market Drivers and Opportunities
6 United States Engineered T Cells Players/Suppliers Profiles and Sales Data
6.1 Autolus Limited
6.1.1 Company Basic Information, Manufacturing Base and Competitors
6.1.2 Engineered T Cells Product Category, Application and Specification
6.1.2.1 Product A
6.1.2.2 Product B
6.1.3 Autolus Limited Engineered T Cells Sales, Revenue, Price and Gross Margin (2013-2018)
6.1.4 Main Business/Business Overview
6.2 Bellicum Pharmaceuticals
6.2.2 Engineered T Cells Product Category, Application and Specification
6.2.2.1 Product A
6.2.2.2 Product B
6.2.3 Bellicum Pharmaceuticals Engineered T Cells Sales, Revenue, Price and Gross Margin (2013-2018)
6.2.4 Main Business/Business Overview
6.3 Cells Medica
6.3.2 Engineered T Cells Product Category, Application and Specification
6.3.2.1 Product A
6.3.2.2 Product B
6.3.3 Cells Medica Engineered T Cells Sales, Revenue, Price and Gross Margin (2013-2018)
6.3.4 Main Business/Business Overview
6.4 Elli Lilly and Company
6.4.2 Engineered T Cells Product Category, Application and Specification
6.4.2.1 Product A
6.4.2.2 Product B
6.4.3 Elli Lilly and Company Engineered T Cells Sales, Revenue, Price and Gross Margin (2013-2018)
6.4.4 Main Business/Business Overview
6.5 Gilead Sciences
6.5.2 Engineered T Cells Product Category, Application and Specification
6.5.2.1 Product A
6.5.2.2 Product B
6.5.3 Gilead Sciences Engineered T Cells Sales, Revenue, Price and Gross Margin (2013-2018)
6.5.4 Main Business/Business Overview
6.6 Juno Therapeutics
6.6.2 Engineered T Cells Product Category, Application and Specification
6.6.2.1 Product A
6.6.2.2 Product B
6.6.3 Juno Therapeutics Engineered T Cells Sales, Revenue, Price and Gross Margin (2013-2018)
6.6.4 Main Business/Business Overview
6.7 Novartis
6.7.2 Engineered T Cells Product Category, Application and Specification
6.7.2.1 Product A
6.7.2.2 Product B
6.7.3 Novartis Engineered T Cells Sales, Revenue, Price and Gross Margin (2013-2018)
6.7.4 Main Business/Business Overview
6.8 Oxford Biomedica
6.8.2 Engineered T Cells Product Category, Application and Specification
6.8.2.1 Product A
6.8.2.2 Product B
6.8.3 Oxford Biomedica Engineered T Cells Sales, Revenue, Price and Gross Margin (2013-2018)
6.8.4 Main Business/Business Overview
6.9 Pfizer
6.9.2 Engineered T Cells Product Category, Application and Specification
6.9.2.1 Product A
6.9.2.2 Product B
6.9.3 Pfizer Engineered T Cells Sales, Revenue, Price and Gross Margin (2013-2018)
6.9.4 Main Business/Business Overview
6.10 Precision Bioscience
6.10.2 Engineered T Cells Product Category, Application and Specification
6.10.2.1 Product A
6.10.2.2 Product B
6.10.3 Precision Bioscience Engineered T Cells Sales, Revenue, Price and Gross Margin (2013-2018)
6.10.4 Main Business/Business Overview
6.11 Redmile Group
6.12 Seeking Alpha
6.13 Unum Therapeutics
7 Engineered T Cells Manufacturing Cost Analysis
7.1 Engineered T Cells Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Price Trend of Key Raw Materials
7.1.3 Key Suppliers of Raw Materials
7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.2.1 Raw Materials
7.2.2 Labor Cost
7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Engineered T Cells
8 Industrial Chain, Sourcing Strategy and Downstream Buyers
8.1 Engineered T Cells Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Engineered T Cells Major Manufacturers in 2017
8.4 Downstream Buyers
9 Marketing Strategy Analysis, Distributors/Traders
9.1 Marketing Channel
9.1.1 Direct Marketing
9.1.2 Indirect Marketing
9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
9.2.1 Pricing Strategy
9.2.2 Brand Strategy
9.2.3 Target Client
9.3 Distributors/Traders List
10 Market Effect Factors Analysis
10.1 Technology Progress/Risk
10.1.1 Substitutes Threat
10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change
11 United States Engineered T Cells Market Size (Value and Volume) Forecast (2018-2025)
11.1 United States Engineered T Cells Sales Volume, Revenue Forecast (2018-2025)
11.2 United States Engineered T Cells Sales Volume Forecast by Type (2018-2025)
11.3 United States Engineered T Cells Sales Volume Forecast by Application (2018-2025)
11.4 United States Engineered T Cells Sales Volume Forecast by Region (2018-2025)
12 Research Findings and Conclusion
13 Appendix
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
List of Tables and Figures
Figure Product Picture of Engineered T Cells
Figure United States Engineered T Cells Market Size (K Units) by Type (2013-2025)
Figure United States Engineered T Cells Sales Volume Market Share by Type (Product Category) in 2017
Figure Tumor Infiltrating Lymphocytes Product Picture
Figure T Cell Receptor {TCR} Product Picture
Figure Chimeric Antigen Receptor (CAR) Product Picture
Figure United States Engineered T Cells Market Size (K Units) by Application (2013-2025)
Figure United States Sales Market Share of Engineered T Cells by Application in 2017
Figure Hospitals Examples
Table Key Downstream Customer in Hospitals
Figure Cancer Research Centers Examples
Table Key Downstream Customer in Cancer Research Centers
Figure Clinics Examples
Table Key Downstream Customer in Clinics
Figure United States Engineered T Cells Market Size (Million USD) by Region (2013-2025)
Figure The West Engineered T Cells Revenue (Million USD) and Growth Rate (2013-2025)
Figure Southwest Engineered T Cells Revenue (Million USD) and Growth Rate (2013-2025)
Figure The Middle Atlantic Engineered T Cells Revenue (Million USD) and Growth Rate (2013-2025)
Figure New England Engineered T Cells Revenue (Million USD) and Growth Rate (2013-2025)
Figure The South of US Engineered T Cells Revenue (Million USD) and Growth Rate (2013-2025)
Figure The Midwest Engineered T Cells Revenue (Million USD) and Growth Rate (2013-2025)
Figure United States Engineered T Cells Sales (K Units) and Growth Rate (2013-2025)
Figure United States Engineered T Cells Revenue (Million USD) and Growth Rate (2013-2025)
Figure United States Engineered T Cells Market Major Players Product Sales Volume (K Units) (2013-2018)
Table United States Engineered T Cells Sales (K Units) of Key Players/Suppliers (2013-2018)
Table United States Engineered T Cells Sales Share by Players/Suppliers (2013-2018)
Figure 2017 United States Engineered T Cells Sales Share by Players/Suppliers
Figure 2017 United States Engineered T Cells Sales Share by Players/Suppliers
Figure United States Engineered T Cells Market Major Players Product Revenue (Million USD) (2013-2018)
Table United States Engineered T Cells Revenue (Million USD) by Players/Suppliers (2013-2018)
Table United States Engineered T Cells Revenue Share by Players/Suppliers (2013-2018)
Figure 2017 United States Engineered T Cells Revenue Share by Players/Suppliers
Figure 2017 United States Engineered T Cells Revenue Share by Players/Suppliers
Table United States Market Engineered T Cells Average Price (USD/Unit) of Key Players/Suppliers (2013-2018)
Figure United States Market Engineered T Cells Average Price (USD/Unit) of Key Players/Suppliers in 2017
Figure United States Engineered T Cells Market Share of Top 3 Players/Suppliers
Figure United States Engineered T Cells Market Share of Top 5 Players/Suppliers
Table United States Players/Suppliers Engineered T Cells Manufacturing Base Distribution and Sales Area
Table United States Players/Suppliers Engineered T Cells Product Category
Table United States Engineered T Cells Sales (K Units) by Region (2013-2018)
Table United States Engineered T Cells Sales Share by Region (2013-2018)
Figure United States Engineered T Cells Sales Share by Region (2013-2018)
Figure United States Engineered T Cells Sales Market Share by Region in 2017
Table United States Engineered T Cells Revenue (Million USD) and Market Share by Region (2013-2018)
Table United States Engineered T Cells Revenue Share by Region (2013-2018)
Figure United States Engineered T Cells Revenue Market Share by Region (2013-2018)
Figure United States Engineered T Cells Revenue Market Share by Region in 2017
Table United States Engineered T Cells Price (USD/Unit) by Region (2013-2018)
Table United States Engineered T Cells Sales (K Units) by Type (2013-2018)
Table United States Engineered T Cells Sales Share by Type (2013-2018)
Figure United States Engineered T Cells Sales Share by Type (2013-2018)
Figure United States Engineered T Cells Sales Market Share by Type in 2017
Table United States Engineered T Cells Revenue (Million USD) and Market Share by Type (2013-2018)
Table United States Engineered T Cells Revenue Share by Type (2013-2018)
Figure Revenue Market Share of Engineered T Cells by Type (2013-2018)
Figure Revenue Market Share of Engineered T Cells by Type in 2017
Table United States Engineered T Cells Price (USD/Unit) by Types (2013-2018)
Figure United States Engineered T Cells Sales Growth Rate by Type (2013-2018)
Table United States Engineered T Cells Sales (K Units) by Application (2013-2018)
Table United States Engineered T Cells Sales Market Share by Application (2013-2018)
Figure United States Engineered T Cells Sales Market Share by Application (2013-2018)
Figure United States Engineered T Cells Sales Market Share by Application in 2017
Table United States Engineered T Cells Sales Growth Rate by Application (2013-2018)
Figure United States Engineered T Cells Sales Growth Rate by Application (2013-2018)
Table Autolus Limited Basic Information List
Table Autolus Limited Engineered T Cells Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Autolus Limited Engineered T Cells Sales Growth Rate (2013-2018)
Figure Autolus Limited Engineered T Cells Sales Market Share in United States (2013-2018)
Figure Autolus Limited Engineered T Cells Revenue Market Share in United States (2013-2018)
Table Bellicum Pharmaceuticals Basic Information List
Table Bellicum Pharmaceuticals Engineered T Cells Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Bellicum Pharmaceuticals Engineered T Cells Sales Growth Rate (2013-2018)
Figure Bellicum Pharmaceuticals Engineered T Cells Sales Market Share in United States (2013-2018)
Figure Bellicum Pharmaceuticals Engineered T Cells Revenue Market Share in United States (2013-2018)
Table Cells Medica Basic Information List
Table Cells Medica Engineered T Cells Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Cells Medica Engineered T Cells Sales Growth Rate (2013-2018)
Figure Cells Medica Engineered T Cells Sales Market Share in United States (2013-2018)
Figure Cells Medica Engineered T Cells Revenue Market Share in United States (2013-2018)
Table Elli Lilly and Company Basic Information List
Table Elli Lilly and Company Engineered T Cells Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Elli Lilly and Company Engineered T Cells Sales Growth Rate (2013-2018)
Figure Elli Lilly and Company Engineered T Cells Sales Market Share in United States (2013-2018)
Figure Elli Lilly and Company Engineered T Cells Revenue Market Share in United States (2013-2018)
Table Gilead Sciences Basic Information List
Table Gilead Sciences Engineered T Cells Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Gilead Sciences Engineered T Cells Sales Growth Rate (2013-2018)
Figure Gilead Sciences Engineered T Cells Sales Market Share in United States (2013-2018)
Figure Gilead Sciences Engineered T Cells Revenue Market Share in United States (2013-2018)
Table Juno Therapeutics Basic Information List
Table Juno Therapeutics Engineered T Cells Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Juno Therapeutics Engineered T Cells Sales Growth Rate (2013-2018)
Figure Juno Therapeutics Engineered T Cells Sales Market Share in United States (2013-2018)
Figure Juno Therapeutics Engineered T Cells Revenue Market Share in United States (2013-2018)
Table Novartis Basic Information List
Table Novartis Engineered T Cells Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Novartis Engineered T Cells Sales Growth Rate (2013-2018)
Figure Novartis Engineered T Cells Sales Market Share in United States (2013-2018)
Figure Novartis Engineered T Cells Revenue Market Share in United States (2013-2018)
Table Oxford Biomedica Basic Information List
Table Oxford Biomedica Engineered T Cells Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Oxford Biomedica Engineered T Cells Sales Growth Rate (2013-2018)
Figure Oxford Biomedica Engineered T Cells Sales Market Share in United States (2013-2018)
Figure Oxford Biomedica Engineered T Cells Revenue Market Share in United States (2013-2018)
Table Pfizer Basic Information List
Table Pfizer Engineered T Cells Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Pfizer Engineered T Cells Sales Growth Rate (2013-2018)
Figure Pfizer Engineered T Cells Sales Market Share in United States (2013-2018)
Figure Pfizer Engineered T Cells Revenue Market Share in United States (2013-2018)
Table Precision Bioscience Basic Information List
Table Precision Bioscience Engineered T Cells Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Precision Bioscience Engineered T Cells Sales Growth Rate (2013-2018)
Figure Precision Bioscience Engineered T Cells Sales Market Share in United States (2013-2018)
Figure Precision Bioscience Engineered T Cells Revenue Market Share in United States (2013-2018)
Table Redmile Group Basic Information List
Table Seeking Alpha Basic Information List
Table Unum Therapeutics Basic Information List
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Engineered T Cells
Figure Manufacturing Process Analysis of Engineered T Cells
Figure Engineered T Cells Industrial Chain Analysis
Table Raw Materials Sources of Engineered T Cells Major Players/Suppliers in 2017
Table Major Buyers of Engineered T Cells
Table Distributors/Traders List
Figure United States Engineered T Cells Sales Volume (K Units) and Growth Rate Forecast (2018-2025)
Figure United States Engineered T Cells Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure United States Engineered T Cells Price (USD/Unit) Trend Forecast (2018-2025)
Table United States Engineered T Cells Sales Volume (K Units) Forecast by Type (2018-2025)
Figure United States Engineered T Cells Sales Volume (K Units) Forecast by Type (2018-2025)
Figure United States Engineered T Cells Sales Volume (K Units) Forecast by Type in 2025
Table United States Engineered T Cells Sales Volume (K Units) Forecast by Application (2018-2025)
Figure United States Engineered T Cells Sales Volume (K Units) Forecast by Application (2018-2025)
Figure United States Engineered T Cells Sales Volume (K Units) Forecast by Application in 2025
Table United States Engineered T Cells Sales Volume (K Units) Forecast by Region (2018-2025)
Table United States Engineered T Cells Sales Volume Share Forecast by Region (2018-2025)
Figure United States Engineered T Cells Sales Volume Share Forecast by Region (2018-2025)
Figure United States Engineered T Cells Sales Volume Share Forecast by Region in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
Speak to the report author to design an exclusive study to serve your research needs.
Your personal and confidential information is safe and secure.
